Filing Details

Accession Number:
0001017491-14-000096
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-24 14:41:59
Reporting Period:
2014-10-22
Filing Date:
2014-10-24
Accepted Time:
2014-10-24 14:41:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1017491 Apricus Biosciences Inc. APRI Pharmaceutical Preparations (2834) 870449967
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235945 Wendall Wierenga 11975 El Camino Real, Suite 300
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-22 20,000 $1.52 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.